Loomis Sayles Announces Changes to Global Fixed Income Team Leadership
Loomis, Sayles & Company, an affiliate of Natixis Investment Managers, announced today that Kenneth Buntrock, portfolio manager and co-team leader of the global fixed income team, will retire in March 2019 after 21 years with the company. In preparation for Ken’s retirement, longstanding portfolio managers Lynda Schweitzer and Scott Service will assume leadership roles effective immediately, joining David Rolley as co-team leaders. The team oversees approximately $29.61 billion in institutional and retail assets for global clients.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180909005021/en/
“We are grateful to Ken for more than 20 years of service and leadership at Loomis Sayles,” said Kevin Charleston, chief executive officer. “His dedication is reflected within the success and growth of the Loomis Sayles global bond capabilities over the past two decades, and we wish him the best in retirement.”
Until his retirement date, Ken will continue in his leadership and portfolio management roles to ensure a seamless transition and provide continuity for clients.
This transition is part of a comprehensive succession plan that was initiated in 2007, when Lynda was named portfolio manager following her six-year tenure as a global portfolio specialist and trader for the team. Similarly, Scott joined the team in 2004, became portfolio manager on a variety of global credit strategies in 2011 and was named portfolio manager on all remaining global bond products in 2014.
“We believe this is the ideal time to elevate Lynda and Scott in recognition of their tenure, experience and track records as portfolio managers,” said Jae Park, chief investment officer. “Lynda and Scott have been vital members of the global fixed income team working in close partnership with Ken and David for over 15 years, and their leadership will be integral to the success of our global bond capabilities moving forward.”
David Rolley will continue his portfolio management responsibilities with Lynda and Scott for the global fixed income portfolios, as well as the emerging market fixed income team portfolios. There will be no changes to the team’s style or investment philosophy. David, Lynda and Scott will continue to report to Jae Park, chief investment officer.
BIOGRAPHICAL INFORMATION: DAVID W. ROLLEY, CFA
David Rolley is a vice president, portfolio manager and co-team leader of the global fixed income team and emerging market debt group at Loomis, Sayles & Company. With 38 years of investment industry experience, David co-manages a suite of global bond, global credit and global allocation products. Prior to joining Loomis Sayles in 1994, he was a principal and director of international capital market research at DRI/McGraw-Hill. His responsibilities included international interest rate and currency forecasting, and risk management consulting. David was also corporate vice president and senior US economist for the institutional equity group at Drexel Burnham Lambert, and chief financial economist at Chase Econometrics. David earned a BA from Occidental College and studied post-graduate economics at the University of Pennsylvania. He is a past president of the Boston Association of Business Economists.
BIOGRAPHICAL INFORMATION: LYNDA SCHWEITZER, CFA
Lynda Schweitzer is a vice president portfolio manager and co-team leader of the global fixed income team at Loomis, Sayles & Company. With 32 years of investment industry experience, she co-manages a suite of global bond and global credit products. Lynda is also a member of the macro strategies, developed markets sovereign and global credit sector teams. Prior to joining Loomis Sayles in 2001 as a global portfolio specialist and trader, she worked at Putnam Investments as a global bond trader for both developed and emerging markets. In her tenure at Putnam, Lynda was also a global fixed income trading assistant and custody operations supervisor. Previously, she worked for State Street Bank and Trust Co. as a fund accountant, responsible for custody and pricing of global fixed income funds. Lynda earned a BA from the University of Rochester and an MBA from Boston University.
BIOGRAPHICAL INFORMATION: SCOTT M. SERVICE, CFA
Scott Service is a vice president, portfolio manager and co-team leader of the global fixed income team at of Loomis, Sayles & Company. He co-manages a suite of global bond and global credit products. Scott joined Loomis Sayles in 1995 and was promoted to credit analyst in 1999. Between 2001 and 2003, he worked in Paris for Loomis Sayles’ parent company, Natixis Investment Managers, covering European credits across various industries and honing his international credit analysis skills. Scott returned to the Loomis Sayles fixed income team in 2003 and became leader of the global credit sector team. In 2004, he joined the global fixed income team. Previously Scott he held financial accounting positions at both State Street Bank and PNC Bank. He earned a BS from Babson College and an MBA from Bentley College.
ABOUT LOOMIS SAYLES
Since 1926, Loomis, Sayles & Company has helped fulfill the investment needs of institutional and mutual fund clients worldwide. The firm’s performance-driven investors integrate deep proprietary research and integrated risk analysis to make informed, judicious decisions. Teams of portfolio managers, strategists, research analysts and traders collaborate to assess market sectors and identify investment opportunities wherever they may lie, within traditional asset classes or among a range of alternative investments. Loomis Sayles has the resources, foresight and the flexibility to look far and wide for value in broad and narrow markets in its commitment to deliver attractive sustainable returns for clients. This rich tradition has earned Loomis Sayles the trust and respect of clients worldwide, for whom it manages $264.4 billion** in assets (as of June 30, 2018).
Total strategy assets include all assets managed by the respective team.
**Includes the assets of Loomis, Sayles & Co., LP, and Loomis Sayles Trust Company, LLC. Loomis Sayles Trust Company is a wholly owned subsidiary of Loomis, Sayles & Company, LP.
ABOUT NATIXIS INVESTMENT MANAGERS
Natixis Investment Managers serves financial professionals with more insightful ways to construct portfolios. Powered by the expertise of 26 specialized investment managers globally, we apply Active Thinking℠ to deliver proactive solutions that help clients pursue better outcomes in all markets. Natixis ranks among the world’s largest asset management firms¹ ($988.4 billion / €846.5 billion AUM²).
Natixis Investment Managers includes all of the investment management and distribution entities affiliated with Natixis Distribution, L.P. and Natixis Investment Managers S.A.
¹Cerulli Quantitative Update: Global Markets 2018 ranked Natixis
Investment Managers as the 16th largest asset manager in the world based
on assets under management as of December 31, 2017.
² Net asset value as of June 30, 2018. Assets under management (“AUM”), as reported, may include notional assets, assets serviced, gross assets and other types of non-regulatory AUM.
1 As of July 31, 2018.
Loomis, Sayles & Company
Orla O’Brien, +1 617-478-7480
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Pioneering Project for Pharmaceutics – Vifor Pharma and the University of Basel are Jointly Establishing the World’s First Research Professorship for Nanopharmaceutical and Regulatory Science26.5.2019 07:00:00 CEST | Pressemelding
Nanopharmaceutics promises ground-breaking innovation in the development of medicines: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190526005014/en/ The Vifor Pharma Group is endowing two professorships for Nanopharmaceutical and Regulatory Science at the University of Basel The commitment by Vifor Pharma and the University of Basel is aimed at ensuring Switzerland has the specialist knowledge and equipment needed to compete globally in this important emerging area of life sciences With this decision, Vifor Pharma is demonstrating its commitment to Switzerland as a world-leading location for pharmaceutical research and development Nanomedicines are playing an increasingly important role in the development of innovative new medications. These drugs are able to overcome specific cellular barriers in the human body with a view to targeting their effect even more precisely. Nanopharmacy therefore promises to help advance medic
XINHUANET: Promotion Event of The Most Beautiful Shooting Location in China Held During Cannes Film Festival25.5.2019 18:20:00 CEST | Pressemelding
On May 16 (local time), an event was held at the 72nd Cannes Film Festival to recommend China’s most beautiful shooting locations on the theme of “Fascinating China.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190525005008/en/ The representative from Cannes Convention Bureau (1st L), Michel Chevillon (C), vice president of the French Riviera Chamber of Commerce and Industry and head of hotel association, and Adeline CHAUVEAU (3rd R), officer in charge of film and television projects from French Embassy to China, pose for a group photo with the representatives from the cities awarded for "The most beautiful shooting location in China." (Photo: Business Wire) In the event, the Yellow Sea National Forest Park in Dongtai, Jiangsu Province, the One Hundred Mile Azalea Forest in Bijie, Guizhou Province, Siming District of Xiamen, Fujian Province, and the Li Autonomous County in Lingshui, Hainan Province were on the list. The p
Knopp Biosciences Presents Positive Preclinical Data for Lead Neonatal Epilepsy Drug Candidate at 2019 Antiepileptic Drug and Device Trials XV Conference24.5.2019 14:00:00 CEST | Pressemelding
Knopp Biosciences LLC, a privately held drug discovery and development company focused on delivering breakthrough treatments for inflammatory and neurological diseases of high unmet need, today presented in vitro and in vivo data for the company’s lead molecule for the targeted treatment of KCNQ2-neonatal epileptic encephalopathy (KCNQ2-NEE) at the Antiepileptic Drug and Device Trials XV Conference in Miami, Florida. KCNQ2-NEE, a rare infant genetic epilepsy, results from mutations in genes encoding the Kv7.2/Kv7.3 ion channel, leading to frequent seizures and profound developmental delay. The preclinical data were presented by Steven Dworetzky, Ph.D., Knopp’s Chief Scientific Officer, a longtime Kv7 researcher who led the group that first cloned the Kv7.2 and Kv7.3 genes during his former tenure with the Bristol-Myers Squibb Co. Dr. Dworetzky presented results demonstrating the in vitro nanomolar activity of KB-3061 and its significant seizure protection in the maximal electroshock mo
Accelerate Your Business in South Korea Through 2019 K-Startup Grand Challenge24.5.2019 10:20:00 CEST | Pressemelding
Entrepreneurs from across the globe should set their sights on participating in the 2019 K-Startup Grand Challenge. Supported by the Ministry of SMEs and Startups and National IT Industry Promotion Agency (NIPA) of South Korea, the initiative provides invaluable support and comprehensive resources to early age startups. Applications for the K-Startup Grand Challenge are currently being accepted through June 14, 2019. In order to advance in the program, teams must pass a regional audition. A judging panel of startup ecosystem experts and Korean accelerators will select 40 teams to participate in an enriching 3.5 month-long acceleration program in Korea. The selected teams will have exclusive access to free office space at the Startup Campus in Pangyo Techno Valley, one-on-one mentoring, information sessions, coaching on Korean and Asian business culture and the chance to attend insightful seminars on accounting regulations to tax laws, patents and more. Opportunities for networking with
New Investigational Clinical Data for Ipsen’s Oncology Products in 11 Solid Tumor Types to Be Presented at 2019 ASCO Annual Meeting24.5.2019 05:00:00 CEST | Pressemelding
Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced that new data from clinical studies on investigational uses of cancer medicines cabozantinib (Cabometyx®), liposomal irinotecan (Onivyde®), and lanreotide autogel (Somatuline®, marketed as Somatuline Depot® in the United States) will be presented at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting. The meeting takes place in Chicago, Illinois, U.S., 31 May–4 June 2019; data featuring Ipsen medicines includes: New data from the Phase 3 CELESTIAL trial on the association of adverse events with efficacy outcomes for cabozantinib in patients with advanced hepatocellular carcinoma Overview of the Phase 3 COSMIC-312 trial of cabozantinib in combination with atezolizumab vs sorafenib in patients with advanced hepatocellular carcinoma who have not received previous systemic anticancer therapy First Phase 2 data from the CaboGIST study (trial 1317) from the European Organization for Research and Treatment of
The Posiflex Group Showcases an Ecosystem of Connected Solution Endpoints with IoT Remote Monitoring at Computex 201924.5.2019 01:00:00 CEST | Pressemelding
For the Computex 2019 show, The Posiflex Group is featuring leading solution technology from the family of brands as a fully Serviced IoT Ecosystem. Solution end points include: Connected Modular Kiosks, POS Terminals, and Digital Signage solutions from Posiflex and KIOSK Information Systems Smart Medical Displays with gesture controls from Portwell Connected Gaming Solutions with Player Tracking Technology from Portwell subsidiary, Ganlot The booth display is based on common field service endpoints represented in a European Manor Destination Resort setting. Field solutions for an array of vertical market applications include QSR ordering, cinema ticketing, fashion retail customer loyalty, interactive signage, hotel / medical center check-in and bill pay, as well as casino gaming technology. This year, in addition to their renowned POS product suite, Posiflex will be featuring newly introduced Modular Kiosk platforms (co-designed by KIOSK and Posiflex), which are configure-to-order sta